ICU設定における鎮静の世界市場:規模・現状・予測2019-2025

【英語タイトル】Global Sedation In ICU Setting Market Size, Status and Forecast 2019-2025

QYResearchが出版した調査資料(DATA909X18948)・商品コード:DATA909X18948
・発行会社(調査会社):QYResearch
・発行日:2019年11月25日(※2024年版があります。お問い合わせください)
・ページ数:99
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
※当調査レポートでは、ICU設定における鎮静の世界市場について調査・分析し、ICU設定における鎮静の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別(プロポフォール、デクスメデトミジン、レミフェンタニル、その他)、用途別(新生児集中治療室、小児集中治療室、成人集中治療室)、地域別(北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米)に区分して市場規模を算出しました。


・レポートの概要
・世界のICU設定における鎮静市場動向
・主要企業別マーケットシェア
・ICU設定における鎮静の種類別市場規模2014-2019
(プロポフォール、デクスメデトミジン、レミフェンタニル、その他)
・ICU設定における鎮静の用途別市場規模2014-2019
(新生児集中治療室、小児集中治療室、成人集中治療室)
・ICU設定における鎮静の北米市場:主要企業・種類別/用途別市場規模
・ICU設定における鎮静のヨーロッパ市場:主要企業・種類別/用途別市場規模
・ICU設定における鎮静の中国市場:主要企業・種類別/用途別市場規模
・ICU設定における鎮静の日本国内市場:主要企業・種類別/用途別市場規模
・ICU設定における鎮静の東南アジア市場:主要企業・種類別/用途別市場規模
・ICU設定における鎮静のインド市場:主要企業・種類別/用途別市場規模
・ICU設定における鎮静の中南米市場:主要企業・種類別/用途別市場規模
・主要企業のプロフィール
(AstraZeneca、GlaxoSmithKline、Mylan、Fresenius、Teva、B. Braun Holding、Aspen)
・ICU設定における鎮静の市場規模予測2019-2025
(種類別、用途別、地域別市場予測)
・アナリストの観点・結論
...
【レポートの概要】

Sedation is the reduction of irritability or agitation by administration of sedative drugs, generally to facilitate a medical procedure or diagnostic procedure.In 2018, the global Sedation In ICU Setting market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Sedation In ICU Setting status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Sedation In ICU Setting development in North America, Europe and Asia-Pacific.

The key players covered in this study
AstraZeneca
GlaxoSmithKline
Mylan
Fresenius
Teva
B. Braun Holding
Aspen

Market segment by Type, the product can be split into
Propofol
Dexmedetomidine
Remifentanil
Others

Market segment by Application, split into
Neonatal Intensive Care Unit
Child Intensive Care Unit
Adult Intensive Care Unit

Market segment by Regions/Countries, this report covers
North America
Europe
Asia-Pacific

The study objectives of this report are:
To analyze global Sedation In ICU Setting status, future forecast, growth opportunity, key market and key players.
To present the Sedation In ICU Setting development in North America, Europe and Asia-Pacific.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Sedation In ICU Setting are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Sedation In ICU Setting Market Size Growth Rate by Type (2014-2025)
1.4.2 Propofol
1.4.3 Dexmedetomidine
1.4.4 Remifentanil
1.4.5 Others
1.5 Market by Application
1.5.1 Global Sedation In ICU Setting Market Share by Application (2019-2025)
1.5.2 Neonatal Intensive Care Unit
1.5.3 Child Intensive Care Unit
1.5.4 Adult Intensive Care Unit
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Sedation In ICU Setting Market Size
2.2 Sedation In ICU Setting Growth Trends by Regions
2.2.1 Sedation In ICU Setting Market Size by Regions (2019-2025)
2.2.2 Sedation In ICU Setting Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players
3.1 Sedation In ICU Setting Market Size by by Players
3.1.1 Global Sedation In ICU Setting Revenue by by Players (2014-2019)
3.1.2 Global Sedation In ICU Setting Revenue Market Share by by Players (2014-2019)
3.1.3 Global Sedation In ICU Setting Market Concentration Ratio (CR5 and HHI)
3.2 Sedation In ICU Setting Key Players Head office and Area Served
3.3 Key Players Sedation In ICU Setting Product/Solution/Service
3.4 Date of Enter into Sedation In ICU Setting Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Sedation In ICU Setting Market Size by Type (2014-2019)
4.2 Global Sedation In ICU Setting Market Size by Application (2014-2019)

5 North America
5.1 North America Sedation In ICU Setting Market Size (2014-2019)
5.2 Sedation In ICU Setting Key Players in North America
5.3 North America Sedation In ICU Setting Market Size by Type
5.4 North America Sedation In ICU Setting Market Size by Application

6 Europe
6.1 Europe Sedation In ICU Setting Market Size (2014-2019)
6.2 Sedation In ICU Setting Key Players in Europe
6.3 Europe Sedation In ICU Setting Market Size by Type
6.4 Europe Sedation In ICU Setting Market Size by Application

7 Asia-Pacific
7.1 Asia-Pacific Sedation In ICU Setting Market Size (2014-2019)
7.2 Sedation In ICU Setting Key Players in Asia-Pacific
7.3 Asia-Pacific Sedation In ICU Setting Market Size by Type
7.4 Asia-Pacific Sedation In ICU Setting Market Size by Application

8 International Players Profiles
8.1 AstraZeneca
8.1.1 AstraZeneca Company Details
8.1.2 Company Description and Business Overview
8.1.3 Sedation In ICU Setting Introduction
8.1.4 AstraZeneca Revenue in Sedation In ICU Setting Business (2014-2019))
8.1.5 AstraZeneca Recent Development
8.2 GlaxoSmithKline
8.2.1 GlaxoSmithKline Company Details
8.2.2 Company Description and Business Overview
8.2.3 Sedation In ICU Setting Introduction
8.2.4 GlaxoSmithKline Revenue in Sedation In ICU Setting Business (2014-2019)
8.2.5 GlaxoSmithKline Recent Development
8.3 Mylan
8.3.1 Mylan Company Details
8.3.2 Company Description and Business Overview
8.3.3 Sedation In ICU Setting Introduction
8.3.4 Mylan Revenue in Sedation In ICU Setting Business (2014-2019)
8.3.5 Mylan Recent Development
8.4 Fresenius
8.4.1 Fresenius Company Details
8.4.2 Company Description and Business Overview
8.4.3 Sedation In ICU Setting Introduction
8.4.4 Fresenius Revenue in Sedation In ICU Setting Business (2014-2019)
8.4.5 Fresenius Recent Development
8.5 Teva
8.5.1 Teva Company Details
8.5.2 Company Description and Business Overview
8.5.3 Sedation In ICU Setting Introduction
8.5.4 Teva Revenue in Sedation In ICU Setting Business (2014-2019)
8.5.5 Teva Recent Development
8.6 B. Braun Holding
8.6.1 B. Braun Holding Company Details
8.6.2 Company Description and Business Overview
8.6.3 Sedation In ICU Setting Introduction
8.6.4 B. Braun Holding Revenue in Sedation In ICU Setting Business (2014-2019)
8.6.5 B. Braun Holding Recent Development
8.7 Aspen
8.7.1 Aspen Company Details
8.7.2 Company Description and Business Overview
8.7.3 Sedation In ICU Setting Introduction
8.7.4 Aspen Revenue in Sedation In ICU Setting Business (2014-2019)
8.7.5 Aspen Recent Development

9 Market Forecast 2019-2025
9.1 Market Size Forecast by Product (2019-2025)
9.2 Market Size Forecast by Application (2019-2025)
9.3 Market Size Forecast by Regions
9.4 North America
9.5 Europe
9.6 Asia-Pacific

10 Analyst’s Viewpoints/Conclusions

11 Appendix
11.1 Research Methodology
11.1.1 Methodology/Research Approach
11.1.1.1 Research Programs/Design
11.1.1.2 Market Size Estimation
11.1.1.3 Market Breakdown and Data Triangulation
11.1.2 Data Source
11.1.2.1 Secondary Sources
11.1.2.2 Primary Sources
11.2 Disclaimer
11.3 Author Details

List of Tables and Figures

Table Sedation In ICU Setting Key Market Segments
Table Key Players Sedation In ICU Setting Covered
Table Global Sedation In ICU Setting Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Propofol Figures
Table Key Players of Propofol
Figuer Dexmedetomidine Figures
Table Key Players of Dexmedetomidine
Figuer Remifentanil Figures
Table Key Players of Remifentanil
Figuer Others Figures
Table Key Players of Others
Table Global Sedation In ICU Setting Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Sedation In ICU Setting Market Share by Application in 2018 & 2025
Figure Neonatal Intensive Care Unit Case Studies
Figure Child Intensive Care Unit Case Studies
Figure Adult Intensive Care Unit Case Studies
Figure Sedation In ICU Setting Report Years Considered
Figure Global Sedation In ICU Setting Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Sedation In ICU Setting Market Size by Regions 2019-2025 (Million US$)
Table Global Sedation In ICU Setting Market Size by Regions 2019-2025 (Million US$)
Table Global Sedation In ICU Setting Market Share by Regions 2014-2019
Figure Global Sedation In ICU Setting Market Share by Regions 2014-2019
Figure Global Sedation In ICU Setting Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Sedation In ICU Setting Revenue by by Players (2014-2019) (Million US$)
Table Global Sedation In ICU Setting Market Share by by Players (2014-2019)
Figure Global Sedation In ICU Setting Market Share by by Players in 2018
Table Global Sedation In ICU Setting by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Sedation In ICU Setting Product/Solution/Service
Table Date of Enter into Sedation In ICU Setting Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Sedation In ICU Setting Market Size by Type (2014-2019) (Million US$)
Table Global Sedation In ICU Setting Market Size Share by Type (2014-2019)
Figure Global Sedation In ICU Setting Market Size Market Share by Type (2014-2019)
Table Global Sedation In ICU Setting Market Size by Application (2014-2019) (Million US$)
Table Global Sedation In ICU Setting Market Size Share by Application (2014-2019)
Figure Global Sedation In ICU Setting Market Size Market Share by Application (2014-2019)
Figure Global Sedation In ICU Setting Revenue Market Share by Application in 2018
Figure North America Sedation In ICU Setting Market Size 2014-2019 (Million US$)
Table North America Key Players Sedation In ICU Setting Revenue (2018-2019) (Million US$)
Table North America Key Players Sedation In ICU Setting Market Share (2018-2019)
Table North America Sedation In ICU Setting Market Size by Type 2014-2019 (Million US$)
Table North America Sedation In ICU Setting Market Share by Type 2014-2019
Table North America Sedation In ICU Setting Market Size by Application 2014-2019 (Million US$)
Table North America Sedation In ICU Setting Market Share by Application 2014-2019
Figure Europe Sedation In ICU Setting Market Size 2014-2019 (Million US$)
Table Europe Key Players Sedation In ICU Setting Revenue (2018-2019) (Million US$)
Table Europe Key Players Sedation In ICU Setting Market Share (2018-2019)
Table Europe Sedation In ICU Setting Market Size by Type 2014-2019 (Million US$)
Table Europe Sedation In ICU Setting Market Share by Type 2014-2019
Table Europe Sedation In ICU Setting Market Size by Application 2014-2019 (Million US$)
Table Europe Sedation In ICU Setting Market Share by Application 2014-2019
Figure Asia-Pacific Sedation In ICU Setting Market Size 2014-2019 (Million US$)
Table Asia-Pacific Key Players Sedation In ICU Setting Revenue (2018-2019) (Million US$)
Table Asia-Pacific Key Players Sedation In ICU Setting Market Share (2018-2019)
Table Asia-Pacific Sedation In ICU Setting Market Size by Type 2014-2019 (Million US$)
Table Asia-Pacific Sedation In ICU Setting Market Share by Type 2014-2019
Table Asia-Pacific Sedation In ICU Setting Market Size by Application 2014-2019 (Million US$)
Table Asia-Pacific Sedation In ICU Setting Market Share by Application 2014-2019
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Sedation In ICU Setting Business 2014-2019 (Million US$)
Figure AstraZeneca Revenue Growth Rate in Sedation In ICU Setting Business (2014-2019)
Table AstraZeneca Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Sedation In ICU Setting Business 2014-2019 (Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Sedation In ICU Setting Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Mylan Company Details
Table Mylan Revenue in Sedation In ICU Setting Business 2014-2019 (Million US$)
Figure Mylan Revenue Growth Rate in Sedation In ICU Setting Business (2014-2019)
Table Mylan Recent Development
Table Fresenius Company Details
Table Fresenius Revenue in Sedation In ICU Setting Business 2014-2019 (Million US$)
Figure Fresenius Revenue Growth Rate in Sedation In ICU Setting Business (2014-2019)
Table Fresenius Recent Development
Table Teva Company Details
Table Teva Revenue in Sedation In ICU Setting Business 2014-2019 (Million US$)
Figure Teva Revenue Growth Rate in Sedation In ICU Setting Business (2014-2019)
Table Teva Recent Development
Table B. Braun Holding Company Details
Table B. Braun Holding Revenue in Sedation In ICU Setting Business 2014-2019 (Million US$)
Figure B. Braun Holding Revenue Growth Rate in Sedation In ICU Setting Business (2014-2019)
Table B. Braun Holding Recent Development
Table Aspen Company Details
Table Aspen Revenue in Sedation In ICU Setting Business 2014-2019 (Million US$)
Figure Aspen Revenue Growth Rate in Sedation In ICU Setting Business (2014-2019)
Table Aspen Recent Development
Table Global Sedation In ICU Setting Market Size by Regions (Million US$) 2019-2025
Figure Global Sedation In ICU Setting Market Size Share by Regions (2019-2025)
Figure Global Sedation In ICU Setting Market Size Share by Regions in 2025
Figure North America Sedation In ICU Setting Market Size Forecast (2019-2025)(Million USD)
Figure Europe Sedation In ICU Setting Market Size Forecast (2019-2025)(Million USD)
Figure Asia-Pacific Sedation In ICU Setting Market Size Forecast (2019-2025)(Million USD)
Table Global Sedation In ICU Setting Market Size by Product (2019-2025) (Million US$)
Figure Global Sedation In ICU Setting Market Size by Product (2019-2025)
Figure Global Sedation In ICU Setting Market Size by Product in 2025
Table Global Sedation In ICU Setting Market Size by Application (2019-2025) (Million US$)
Figure Global Sedation In ICU Setting Market Size by Application (2019-2025)
Figure Global Sedation In ICU Setting Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

AstraZeneca、GlaxoSmithKline、Mylan、Fresenius、Teva、B. Braun Holding、Aspen

★調査レポート[ICU設定における鎮静の世界市場:規模・現状・予測2019-2025] (コード:DATA909X18948)販売に関する免責事項を必ずご確認ください。
★調査レポート[ICU設定における鎮静の世界市場:規模・現状・予測2019-2025]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆